Figure 5.
Pharmacological targeting of the NLRP3 inflammasome mechanisms. A wide variety of small synthetic molecules, natural compounds, and antibodies have been developed to target the canonical NLRP3 inflammasome signaling components as research tools and medicines in trials and clinics. Natural, but not synthetic, products are labeled in purple.